Health Coaching for Back Pain After Emergency Department Discharge
- Disease/Condition
- Low Back Pain
- Drug/Device/Intervention
- Usual ED Care plus Health Coaching
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Vanderbilt University Medical Center
- Location
- Nashville, United States of America
- Phase
- N/A
- Start date
- May 06, 2024
- End date
- Sep 01, 2025
- Enrollment
- 40 participants
Feasibility - study enrollment,Feasibility - study retention,Feasibility - session attendance,Feasibility - Feasibility of Intervention Measure (FIM),Acceptability - Acceptability of Intervention Measure (AIM),Acceptability - Intervention Appropriateness Measure (IAM),Perceptions of intervention
The goal of this two-group randomized trial is to determine the feasibility and acceptability
 of a remotely-delivered health coaching intervention offered in conjunction with usual care
 for patients with an acute exacerbation of chronic low back pain who present to the emergency
 department (ED).
 
 The main questions this feasibility trial aims to answer are:
 
 - Is our health coaching intervention and randomized trial methodology feasible to
 conduct?
 
 - Is our health coaching intervention acceptable to participants and ED providers?
 
 Participants will be randomized to one of two groups (usual ED care plus health coaching or
 usual ED care plus education) and complete outcome assessments at 3 and 6 months after ED
 discharge. Participants and ED providers will also complete an interview.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06400602
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06400602 through Pure Global AI's free database. This phase not specified trial is sponsored by Vanderbilt University Medical Center and is currently Recruiting. The study focuses on Low Back Pain. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.